Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	QAW039 150 mg	301
Overall Study	STARTED	QAW039 450 mg	295
Overall Study	STARTED	Placebo	298
Overall Study	FAS/SAF: High Eosinophil Subpopulation	QAW039 150 mg	200
Overall Study	FAS/SAF: High Eosinophil Subpopulation	QAW039 450 mg	201
Overall Study	FAS/SAF: High Eosinophil Subpopulation	Placebo	201
Overall Study	FAS/SAF: Overall Population	QAW039 150 mg	299
Overall Study	FAS/SAF: Overall Population	QAW039 450 mg	293
Overall Study	FAS/SAF: Overall Population	Placebo	298
Overall Study	COMPLETED	QAW039 150 mg	282
Overall Study	COMPLETED	QAW039 450 mg	278
Overall Study	COMPLETED	Placebo	269
Overall Study	NOT COMPLETED	QAW039 150 mg	19
Overall Study	NOT COMPLETED	QAW039 450 mg	17
Overall Study	NOT COMPLETED	Placebo	29

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02555683/flow